Xenobiotic-induced neuroanatomic alterations are always regarded as adverse
and are commonly used to define reference doses to manage neurotoxic risk.
Thus, the neuropathologist plays an essential role in evaluating potential
neurotoxicants. The pathologist must be able to recognize the morphologic
differences that exist among species, strains, and ages or between genders
(comparative neuroanatomy) and to grasp the impact of structural damage on
neural function (corrective neuroanatomy). Brain anatomy and function may b
e used to group the mammals used in neurotoxicity bioassays into 3 classes:
rodent, carnivore. and primate. Neural function may or may not be affected
by the structural divergence. Rodents are preferred for neurotoxicity assa
ys because their reduced body size allows optimal perfusion at little cost
and their smaller brain size permits screening of multiple regions using fe
w sections. However, care must be exercised when interpreting rodent neurop
athology data because the rodent paleocortex does not recapitulate the soph
isticated neocortical circuitry and functions of carnivores and primates. K
nowledge of the neuroanatomic variations that exist among test species assi
sts the neuropathologist in defining the relevance of structural alteration
s, the potential clinical sequelae of such findings, and the possible signi
ficance of similar changes in humans.